Vital Signs - Current Treatments for Alchoholism are Underutilized

Vital Signs - Current Treatments for Alchoholism are Underutilized

 

RELEASE DATE
26-Nov-2007
REGION
North America
Research Code: 9561-00-4C-00-00
SKU: HC00508-NA-MR_03980
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00508-NA-MR_03980

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on November 26, 2007, provides a strategic overview of issues and advances in the development of medications for alcoholism. Additionally, a company spotlight is provided for Sirtris Pharmaceuticals, a biopharmaceutical company focused on developing treatments for diseases associated with aging and metabolic disorders. Reimbursement and regulatory news from the FDA is also provided for the week of November 12 - November 16, 2007.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on November 26, 2007, provides a strategic overview of issues and advances in the development of medications for alcoholism. Additionally, a company spotlight is provided for Sirtris Pharmaceuticals, a biopharmaceutical company focused on developing treatments for diseases associated with aging and metabolic disorders. Reimbursement and regulatory news from the FDA is also provided for the week of November 12 - November 16, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-4C-00-00
Is Prebook No